Results 101 to 110 of about 230,574 (171)

Color Doppler imaging of the superior ophthalmic vein in different clinical forms of Graves` orbitopathy

, 2008
To compare color Doppler imaging (CDI) parameters of the superior ophthalmic vein (SOV) in patients with Graves` orbitopathy (GO) and in normal controls. Forty-three GO patients and 14 normal controls underwent CDI of the SOV.
BETINJANE, Alberto J., MONTEIRO, Mario L. R., ANGOTTI-NETO, Helio, BENABOU, Joseph E.   +3 more
core  

Liraglutide reduces lipid accumulation in human orbital fibroblasts in Graves' orbitopathy. [PDF]

Front Endocrinol (Lausanne)
Shih CW, Shih SR, Wei YH, Lin CH, Liao SL, Chou TA, Chu I, Chen HJ, Liao NL, Tsai FC.   +9 more
europepmc   +1 more source

Mouse Model of Graves' Orbitopathy in Current Research and Future Perspectives. [PDF]

Medicina (Kaunas)
Lee GM, Jung WH, Kim Y, Oh MI, Jang SY.
europepmc   +1 more source

Sirolimus for the treatment of Graves' orbitopathy. [PDF]

Thyroid Res
Comi S, Sabini E, Cosentino G, Santini F, Marinò M.   +4 more
europepmc   +1 more source

Dipeptidyl peptidase-4 inhibitors suppress myofibroblastic differentiation and hyaluronan synthesis in Graves' orbitopathy fibroblasts. [PDF]

Front Endocrinol (Lausanne)
Shih CW, Tsai FC, Shih SR, Liao SL, Chu I, Hong TM, Liao NL, Wei YH.   +7 more
europepmc   +1 more source

Development of Graves orbitopathy after thyroidectomy for thyroid cancer. [PDF]

JCEM Case Rep
Hormiz M, Sydenham-Clarke L, Lammoza N, Zajac JD, Grossmann M, Lau LH.   +5 more
europepmc   +1 more source

Evaluation of contrast sensitivity function and optic nerve head in patients diagnosed with graves without orbitopathy

Amaç: Graves hastalarında fonksiyonel göz hasarı gelişmeden önce, subklinik evrede gerçekleştirilecek erken tanı ve uygun takip yöntemleriyle geri dönüşü olmayan görme kaybının önlenmesi amaçlanmıştır. Materyal ve Metod: 30 Graves orbitopatisi olan hasta,
Azız, Marıam
core  

Efficacy and safety of tocilizumab in the treatment of Graves' orbitopathy: a systematic review and meta-analysis. [PDF]

BMC Endocr Disord
Chen J, Chen Y, Huang H, Duan H.
europepmc   +1 more source

Assessment of disease activity in Graves' orbitopathy. [PDF]

Front Ophthalmol (Lausanne)
Potvin ARGG, Lacraru IC, Bisschop PH, de Win MML, Eckstein AK, Saeed P.   +5 more
europepmc   +1 more source

Unilateral proptosis as the manifestation of euthyroid Graves orbitopathy: A case report. [PDF]

Medicine (Baltimore)
Rauniyar S, Pokhrel M, Dhenga S, Chaudhary G, Shrestha B.   +4 more
europepmc   +1 more source